Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-01-2013 | Retinal Disorders

Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy

Authors: Chui Ming Gemmy Cheung, Mayuri Bhargava, Li Xiang, Ranjana Mathur, Chan Choi Mun, Doric Wong, Tien Yin Wong

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 1/2013

Abstract

Background

To determine clinical or imaging prognostic features for visual outcome in eyes with submacular hemorrhage secondary to age-related macular degeneration (AMD) or polypoidal choroidal vasculopathy (PCV).

Methods

A prospective case series of 11 eyes from 11 patients with submacular hemorrhage secondary to AMD or PCV. All participants had measurement of clinical characteristics, fundus angiogram, and indocyanine green angiography, spectral domain optical coherence tomography (OCT, Cirrus, Zeiss) at baseline and 6 months.

Results

Median visual acuity improved from 20/132 to 20/63 at month 6. The median improvement in vision was 0.20 LogMAR units. Proportion of eyes with best-corrected visual acuity (BCVA) ≥1.0 increased from 6/11 (54.5 %) at baseline to 8/11 (72.7 %) at month 6. Eyes with BCVA > 1.0 were more likely to have larger area of hemorrhage and thinner subfoveal neurosensory retinal thickness at baseline and at month 6.

Conclusions

Thinner neurosensory retina demonstrated on OCT at baseline may be a useful prognostic sign for limited visual recovery.

Hochman MA, Seery CM, Zarbin MA (1997) Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol 42:195–213

Scupola A, Coscas G, Soubrane G, Balestrazzi E (1999) Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 213:97–132PubMedCrossRef

Avery RL, Fekrat S, Hawkins BS, Bressler NM (1996) Natural history of subfoveal hemorrhage in age-related macular degeneration. Retina 16:183–189PubMedCrossRef

Kuhli-Hattenbach C, Fischer IB, Schalnus R, Hattenbach L (2010) Subretinal Hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy. Am J Ophthalmol 149:316–321PubMedCrossRef

Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1–8PubMedCrossRef

Cackett P, Htoon H, Wong D, Yeo I (2010) Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population. Eye 24:789–792PubMedCrossRef

Ahuja RM, Stanga PE, Vingerling JR, Reck AC, Bird AC (2000) Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol 84:479–484PubMedCrossRef

Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, Wong TY, Aung T (2010) Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prof Ret Eye Res 29:19–29CrossRef

Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U (2007) Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Am J Ophthalmol 144:886–892PubMedCrossRef

10.

Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW, Bressler NM (2010)) Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina 30:1171–1176CrossRef

11.

Ahmad S, Bearelly S, Stinnet SS, Cooney MJ, Fekrat S (2008) Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration. Am J Ophthalmol 145:1052–1057PubMedCrossRef

12.

Chan WM, Liu DT, Lai TY, Li H, Tong JP, Lam DS (2005) Extensive submacular hemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up. Clin Experiment Ophthalmol 33:611–618PubMedCrossRef

13.

Lewis H (1994) Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118:559–568PubMed

14.

Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS (2001) Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol 119:28–32PubMed

15.

Fang IM, Lin YC, Yang CH, Yang CM, Chen MS (2009) Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration. Eye 23:397–406PubMedCrossRef

16.

Ron Y, Ehrlich R, Axer-Siegel R, Rosenblatt I, Weiberger D (2007) Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration. Ophthalmologica 221:57–61PubMedCrossRef

17.

Haupert CL, McCuen BW 2nd, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA (2001) Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 13:208–215CrossRef

18.

Fine HF, Iranmanesh R, Del Priore LV, Barile GR, Chang LK, Chang S, Schiff WM (2010) Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration. Retina 30(10):1588–1594PubMedCrossRef

19.

Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, Grand MG (1995) Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol 113:62–69PubMedCrossRef

20.

Vander JF, Federan JL, Greven C, Slusher MM, Gabel VP (1991) Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 98:23–27PubMed

21.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Eng J Med 355:1419–1431CrossRef

22.

Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Eng J Med 355:1432–1444CrossRef

23.

Todorich B, Scott IU, Flynn HW Jr, Johnson MW (2011) Evolving strategies in the management of submacular hemorrhage associated with choroidal neovascularization in the anti-vascular endothelial growth factor era. Retina 31:1749–1752PubMedCrossRef

24.

Toth CA, Morse LS, Hjelmeland LM, Landers MB 3rd (1991) Fibrin directs dearly retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 109:723–729PubMedCrossRef

25.

Ito T, Nakano M, Yamamoto Y, Hiramitsu T, Mizuno Y (1995) Hemoglobin-induced lipid peroxidation in the retina: a possible mechanism for macular degeneration. Arch Biochem Biophys 316:864–872PubMedCrossRef

26.

Sawa M, Ober MD, Spaide RF (2006) Autofluorescence and retinal pigment epithelial atrophy after subretinal hemorrhage. Retina 26:119–120PubMedCrossRef

27.

http://www.retinaaustralia.com.au/legal_blindness.htm

28.

http://www.afb.org/section.aspx?SectionID=26&TopicID=144

Title: Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy
Authors: Chui Ming Gemmy Cheung
Mayuri Bhargava
Li Xiang
Ranjana Mathur
Chan Choi Mun
Doric Wong
Tien Yin Wong
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 1/2013
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-012-2029-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections

Tilt and decentration of an intraocular lens implanted in the ciliary sulcus after capsular bag defect during cataract surgery

Ranibizumab for serous macular detachment in branch retinal vein occlusions

Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids

Rosai–Dorfman disease presenting as choroidal melanoma: a case report and review of the literature

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up